This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pickering, J. G. Articles by Isner, J. M. Search for Related Content PubMed PubMed Citation Articles by Pickering, J. G. Articles by Isner, J. M.

Circulation, Vol 89, 13-21, Copyright © 1994 by American Heart Association

ARTICLES

Liposome-mediated gene transfer into human vascular smooth muscle cells

JG Pickering, J Jekanowski, L Weir, S Takeshita, DW Losordo and JM Isner
Department of Medicine (Cardiology), St Elizabeth's Hospital, Tufts University School of Medicine, Boston, Mass. 02135.

BACKGROUND: Complexing recombinant DNA with cationic liposomes is a convenient means of introducing foreign genes into cells (lipofection) and could potentially form the basis for genetically modifying diseased blood vessels in patients. The mechanism of lipofection is incompletely understood, but it is recognized that the degree of successful gene transfer is highly dependent on cell type. To date, there has been no reported experience with lipofection of human vascular smooth muscle cells. METHODS AND RESULTS: Primary cultures of human vascular smooth muscle cells were transfected under optimized conditions with a plasmid expressing either firefly luciferase (Luc) or nuclear-localized beta- galactosidase (NL-beta-gal). Cells were derived from either normal human internal mammary arteries (n = 6), fragments of primary atherosclerotic plaque (n = 4), or fragments of restenotic lesions (n = 5). Concurrent lipofection of rabbit vascular smooth muscle cells and NIH 3T3 cells was performed as well. Cultures derived from 15 patients all demonstrated positive expression of the reporter gene. Compared with NIH 3T3 cells, however, expression in human vascular smooth muscle cells was markedly reduced: in cells derived from internal mammary artery, Luc expression, normalized for protein content, was 123-fold lower than in NIH 3T3 cells, whereas the proportion of cells expressing NL-beta-gal was 30-fold lower. Luc expression in cells derived from restenotic tissue was significantly greater than from cells derived from primary plaque (P < .03). Within a given population of cells, the mitotic index of cells expressing the recombinant gene was significantly higher than the mitotic index for the total population of cells (P < .05). Finally, cotransfection experiments, in which lipofection of smooth muscle cells was performed using genes for NL- beta-gal and for human growth hormone, showed that among positive transfects, a high proportion of cells (23% to 36%) coexpressed both genes. CONCLUSIONS: The efficiency of successful lipofection in human vascular smooth muscle cells in vitro is low. Transfection appears to be preferentially facilitated in cells derived from restenotic tissue, and specific properties of smooth muscle cells, including growth rates, appear to be critical for successful transfection. Further elucidation of cell properties that promote transfection is required to augment the efficiency of liposome-mediated gene transfer in human vascular cells.

This article has been cited by other articles:

				R Tabibiazar and S.G Rockson Angiogenesis and the ischaemic heart Eur. Heart J., June 1, 2001; 22(11): 903 - 918. [PDF]

				J. Dulak, A. Jozkowicz, A. Ratajska, A. Szuba, J. P Cooke, and A. Dembinska-Kiec Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells Vascular Medicine, February 1, 2000; 5(1): 33 - 40. [Abstract] [PDF]

				C. H. Selzman, B. D. Shames, L. L. Reznikov, S. A. Miller, X. Meng, H. A. Barton, A. Werman, A. H. Harken, C. A. Dinarello, and A. Banerjee Liposomal Delivery of Purified Inhibitory-{kappa}B{alpha} Inhibits Tumor Necrosis Factor-{alpha}–Induced Human Vascular Smooth Muscle Proliferation Circ. Res., April 30, 1999; 84(8): 867 - 875. [Abstract] [Full Text] [PDF]

				G J CLESHAM Gene therapy made difficult Heart, October 1, 1998; 80(4): 313 - 314. [Full Text]

				N. L’Heureux, S. Pâquet, R. Labbé, L. Germain, and F. A. Auger A completely biological tissue-engineered human blood vessel FASEB J, January 1, 1998; 12(1): 47 - 56. [Abstract] [Full Text]

				G. J. Clesham, H. Browne, S. Efstathiou, and P. L. Weissberg Enhancer Stimulation Unmasks Latent Gene Transfer After Adenovirus-Mediated Gene Delivery Into Human Vascular Smooth Muscle Cells Circ. Res., December 1, 1996; 79(6): 1188 - 1195. [Abstract] [Full Text]

				J. Dalesandro, H. Akimoto, C. M. Gorman, T. O. McDonald, R. Thomas, H. D. Liggitt, and M. D. Allen GENE THERAPY FOR DONOR HEARTS: EX VIVO LIPOSOME-MEDIATED TRANSFECTION J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 416 - 422. [Abstract] [Full Text]